Insider Transactions last 24 months for Vertex Pharmaceuticals Incorporated  -  NSDQ: VRTX

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Bhatia Sangeeta N.Director08/27/2025DSDirectCOM266$386.69$102,859.544,565
Sachs Bruce IDirector08/06/2025APDirectCOM3,366$389.84$1,312,201.4445,000
Sachs Bruce IDirector08/06/2025APDirectCOM1,634$389.36$636,214.2441,634
Kewalramani ReshmaCEO & President08/06/2025APDirectCOM5,710$389.95$2,226,614.50115,968
Kewalramani ReshmaCEO & President08/06/2025APDirectCOM4,290$389.08$1,669,153.20110,258
Arbuckle Stuart AEVP, COO07/01/2025DFDirectCOM37,243$450.23$16,767,915.8963,368
Altshuler DavidEVP, Chief Scientific Officer05/15/2025DSDirectCOM52$424.69$22,083.8823,281
Arbuckle Stuart AEVP, COO05/13/2025AADirectCOM37,622$0.00$0.00100,611
Bhatia Sangeeta N.Director05/02/2025DSDirectCOM400$505.86$202,344.004,831
Bhatia Sangeeta N.Director05/01/2025AADirectCOM796$0.00$0.005,231
Carney LloydDirector05/01/2025AADirectCOM796$0.00$0.007,115
Garber Alan MDirector05/01/2025AADirectCOM398$0.00$0.006,872
Mckenzie DianaDirector05/01/2025DDDirectCOM1,001$0.00$0.002,231
Mckenzie DianaDirector05/01/2025AADirectCOM796$0.00$0.003,232
Schneider JenniferDirector05/01/2025AADirectCOM796$0.00$0.001,718
Thornberry NancyDirector05/01/2025AADirectCOM398$0.00$0.002,035
Upadhyay SuketuDirector05/01/2025DDDirectCOM1,001$0.00$0.002,354
Upadhyay SuketuDirector05/01/2025AADirectCOM796$0.00$0.003,355
Altshuler DavidEVP, Chief Scientific Officer03/13/2025DSDirectCOM3,231$510.00$1,647,810.0023,281
Altshuler DavidEVP, Chief Scientific Officer03/10/2025DSDirectCOM3,231$500.00$1,615,500.0026,512
Tatsis OuraniaEVP, Chief Reg. & Quality Off.03/10/2025DSDirectCOM3,242$499.99$1,620,967.5851,239
Wagner Charles F JrEVP & Chief Financial Officer03/10/2025DSDirectCOM3,298$500.00$1,649,000.0051,671
Tatsis OuraniaEVP, Chief Reg. & Quality Off.03/04/2025DSDirectCOM4,058$485.49$1,970,118.4254,481
Altshuler DavidEVP, Chief Scientific Officer03/03/2025DSDirectCOM3,231$490.00$1,583,190.0029,743
Altshuler DavidEVP, Chief Scientific Officer02/25/2025DSDirectCOM848$480.95$407,845.6040,200
1   2  3  4  5  6  7  8  9  10  Next Last  You are at page 1 of 11 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel